Alteogen Inc.
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
196170 | KO
Overview
Corporate Details
- ISIN(s):
- KR7196170005
- LEI:
- Country:
- South Korea
- Address:
- 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
- Website:
- http://www.alteogen.com/
Description
Alteogen Inc. is a biopharmaceutical company focused on the development and commercialization of next-generation biologics. The company's core activities are centered on its proprietary platform technologies. These include Hybrozyme™, a novel recombinant human hyaluronidase (ALT-B4) technology that enables the conversion of intravenous (IV) therapies to subcutaneous (SC) formulations, enhancing patient convenience. Additionally, Alteogen develops long-acting biobetters utilizing its NexP™ fusion technology, proprietary antibody-drug conjugates (ADCs), and antibody biosimilars. The company's pipeline is aimed at creating therapies with enhanced efficacy and delivery methods for serious diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-08-27 00:00 |
[기재정정]반기보고서 (2020.06)
|
Korean | 1.3 MB | ||
| 2020-08-14 00:00 |
반기보고서 (2020.06)
|
Korean | 1.3 MB | ||
| 2020-08-04 00:00 |
풍문또는보도에대한해명(미확정)
|
Korean | 5.2 KB | ||
| 2020-07-30 00:00 |
금전대여결정(자율공시)
|
Korean | 8.5 KB | ||
| 2020-07-22 00:00 |
권리락(무상증자)
|
Korean | 3.7 KB | ||
| 2020-07-10 00:00 |
기타경영사항(특허권취득)(자율공시)(혈액응고 인자 VII/VIIa 융합단백질의 제조방법)
|
Korean | 5.3 KB | ||
| 2020-07-07 00:00 |
주요사항보고서(무상증자결정)
|
Korean | 10.1 KB | ||
| 2020-07-07 00:00 |
주권매매거래정지(무상증자)
|
Korean | 4.8 KB | ||
| 2020-07-07 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.6 KB | ||
| 2020-06-30 00:00 |
기업설명회(IR)개최
|
Korean | 8.0 KB | ||
| 2020-06-24 00:00 |
투자판단관련주요경영사항(인간 히알루로니다제 원천 기술(ALT-B4) 비독점적 라이센스 계약 체결)
|
Korean | 10.4 KB | ||
| 2020-06-11 00:00 |
주식매수선택권부여에관한신고
|
Korean | 13.4 KB | ||
| 2020-06-03 00:00 |
풍문또는보도에대한해명
|
Korean | 4.2 KB | ||
| 2020-06-01 00:00 |
투자판단관련주요경영사항(ADC 유방암 치료제(ALT-P7) 임상 1상 시험 결과 미 임상종양학회(ASCO)에서 발표)
|
Korean | 11.7 KB | ||
| 2020-05-25 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 93.3 KB |
Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Alteogen Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Alteogen Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
